Dianthus Therapeutics, Inc. DNTH | $82.89M | 9.41 | 2.76M | +43.26% | +$25.03M | 9.04 | |
Enliven Therapeutics, Inc. ELVN | $56.34M | 6.81 | 3.2M | +50.27% | +$18.85M | 6.14 | |
| Astria Therapeutics, Inc. ATXS | $50.02M | 6.47 | 3.55M | 0% | +$0 | 5.45 | |
| Axsome Therapeutics, Inc. AXSM | $188.33M | 4.97 | 2.36M | 0% | +$0 | 20.53 | |
Cogent Biosciences, Inc. COGT | $31.76M | 4.94 | 4.73M | +32.78% | +$7.84M | 3.46 | |
| Kiniksa Pharmaceuticals, Ltd. KNSA | $63.23M | 4.52 | 3.2M | +11.15% | +$6.35M | 6.89 | |
Apogee Therapeutics, Inc. APGE | $136.13M | 3.51 | 2.05M | -30.35% | -$59.31M | 14.84 | |
| Terns Pharmaceuticals, Inc. TERN | $13.38M | 3.15 | 2.04M | 0% | +$0 | 1.46 | |
| Nuvalent, Inc. NUVL | $144.52M | 2.98 | 1.92M | 0% | +$0 | 15.75 | |
| Viridian Therapeutics, Inc. VRDN | $32.32M | 2.89 | 1.85M | +34.77% | +$8.34M | 3.52 | |
| Tyra Biosciences, Inc. TYRA | $22.85M | 2.65 | 1.39M | 0% | +$0 | 2.49 | |
| Protagonist Therapeutics, Inc. PTGX | $26.96M | 1.59 | 931,890 | New | +$26.96M | 2.94 | |
| Merus N.V. MRUS | $32.3M | 1.22 | 717,254 | 0% | +$0 | 3.52 | |
| Geron Corporation GERN | $22M | 1.12 | 6.67M | New | +$22M | 2.4 | |
Spyre Therapeutics, Inc. SYRE | $14.35M | 0.94 | 378,421 | 0% | +$0 | 1.57 |